Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
Other Sizes |
|
References |
|
---|---|
Additional Infomation |
Dofequidar is an antineoplastic agent.
Dofequidar is an orally-available synthetic quinoline derivative with multidrug resistance modulating properties. Dofequidar binds to the drug-binding site of the transmembrane P-glycoprotein efflux pump and is preferentially transported from the cell, thereby blocking the efflux of other therapeutic agents. |
Molecular Formula |
C30H31N3O3
|
---|---|
Molecular Weight |
481.58544
|
Exact Mass |
481.237
|
CAS # |
129716-58-1
|
PubChem CID |
213040
|
Density |
1.228g/cm3
|
Boiling Point |
720.8ºC at 760mmHg
|
Flash Point |
389.7ºC
|
Vapour Pressure |
8.36E-22mmHg at 25°C
|
Index of Refraction |
1.64
|
LogP |
3.826
|
Hydrogen Bond Donor Count |
1
|
Hydrogen Bond Acceptor Count |
5
|
Rotatable Bond Count |
8
|
Heavy Atom Count |
36
|
Complexity |
652
|
Defined Atom Stereocenter Count |
0
|
SMILES |
OC(COC1=C2C=CC=NC2=CC=C1)CN3CCN(C(C(C4=CC=CC=C4)C5=CC=CC=C5)=O)CC3
|
InChi Key |
KLWUUPVJTLHYIM-UHFFFAOYSA-N
|
InChi Code |
InChI=1S/C30H31N3O3/c34-25(22-36-28-15-7-14-27-26(28)13-8-16-31-27)21-32-17-19-33(20-18-32)30(35)29(23-9-3-1-4-10-23)24-11-5-2-6-12-24/h1-16,25,29,34H,17-22H2
|
Chemical Name |
1-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-2,2-diphenylethanone
|
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.0765 mL | 10.3823 mL | 20.7646 mL | |
5 mM | 0.4153 mL | 2.0765 mL | 4.1529 mL | |
10 mM | 0.2076 mL | 1.0382 mL | 2.0765 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.